Early research (Phase 1)UnknownNCT00969202What this trial is testingStereotactic Hypofractionated Radiosurgery for Early Stage Prostate CancerWho this might be right forProstate Cancer San Diego Radiosurgery 50
Early research (Phase 1)Looking for participantsNCT06673329What this trial is testingBrodalumab in the Treatment of Immune-Related Adverse EventsWho this might be right forBreast CancerEsophageal CancerKidney Cancer+15 more Brian Henick, MD 11
Not applicableActive Not RecruitingNCT02044172What this trial is testingProstate Testing for Cancer and TreatmentWho this might be right forProstate Cancer University of Oxford 82,849
Testing effectiveness (Phase 2)Study completedNCT00003312What this trial is testingBrachytherapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 95
Not applicableStudy completedNCT00292019What this trial is testingRobotic Laparoscopic Radical ProstatectomyWho this might be right forProstate Cancer London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Testing effectiveness (Phase 2)Study completedNCT01942837What this trial is testingStudy of Enzalutamide in Patients With Castration-resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer Dana-Farber Cancer Institute 67
Early research (Phase 1)Ended earlyNCT03436745What this trial is testingThe Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy FemalesWho this might be right forProstatic Neoplasms National Cancer Institute (NCI) 12
Not applicableWithdrawnNCT02905201What this trial is testingA Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)Who this might be right forProstatic Neoplasms Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Ended earlyNCT05256381What this trial is testingSOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid TumorsWho this might be right forNon-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more SOTIO Biotech AG 166
Large-scale testing (Phase 3)Ended earlyNCT00236002What this trial is testingCancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )Who this might be right forOsteoporosis Canadian Urology Research Consortium 182
Not applicableLooking for participantsNCT04172753What this trial is testingFeasibility of Online MR-guided Radiotherapy on a 1.5T MR-LinacWho this might be right forRectal CancerHead and Neck CancerLiver Cancer+4 more University Hospital Tuebingen 472
Large-scale testing (Phase 3)Study completedNCT00247312What this trial is testingPd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized TrialWho this might be right forProstatic Neoplasm Schiffler Cancer Center 319
Large-scale testing (Phase 3)Study completedNCT00030654What this trial is testingHormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 21
Not applicableLooking for participantsNCT05478694What this trial is testingOutcomes of Focal Ablation for Prostate CancerWho this might be right forProstate Cancer University of Texas Southwestern Medical Center 225
Testing effectiveness (Phase 2)Study completedNCT00150995What this trial is testingTetrathiomolybdate in Hormone Refractory Prostate CancerWho this might be right forProstate Cancer University of Michigan Rogel Cancer Center 19
Large-scale testing (Phase 3)Study completedNCT03009981What this trial is testingAndrogen Annihilation in High-Risk Biochemically Relapsed Prostate CancerWho this might be right forProstate Cancer Alliance Foundation Trials, LLC. 504
Not applicableUnknownNCT03979339What this trial is testingFeasibility of a New Technology for Isolating Circulating Tumour CellsWho this might be right forHER2-positive Metastatic Breast CancerOvarian CancerHormone-resistant Prostate Cancer+1 more Centre Oscar Lambret 76
Not applicableActive Not RecruitingNCT03857477What this trial is testingThe BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.Who this might be right forProstate Cancer Institute of Cancer Research, United Kingdom 4,700
Not applicableLooking for participantsNCT07614256What this trial is testingMultimodal Imaging and Digital Pathology for Prostate Cancer PredictionWho this might be right forProstate Cancer (Diagnosis)Clinically Significant Prostate Cancer Guangxi Medical University 3,000
Testing effectiveness (Phase 2)Ended earlyNCT02913131What this trial is testingHyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor MalignanciesWho this might be right forProstate Cancer Rahul Aggarwal 23